Table 4 |
||||
|
Various measurements in patients and controls as means (SD) and number of pathological values |
||||
|
Number with pathological values |
||||
|
|
||||
|
Patients |
Controls |
Patient group |
Controls/Mi controls |
|
|
|
||||
|
Pulse |
78 (14) |
72 (12)* |
2 >100 beats/min (1 CTS, 1 Mi) |
0/0 |
|
Systolic blood pressure |
120 (15) |
112 (10)† |
1 >150 mmHg (stroke) |
0/0 |
|
Diastolic blood pressure |
74 (10) |
72 (8) |
1 >95 mmHg (Mi) |
0/0 |
|
Hemoglobin |
12.9 (1.1) |
12.3 (1.1)† |
4 low (all Mi) |
10/9 low |
|
Platelet count |
250 (74) |
249 (63) |
1 low (MS), 2 high (stroke, Mi) |
2 low, 1 high/2 low, 1 high |
|
ESR |
20 (19) |
16 (12) |
13 high (2 CTS, 1 stroke, 1 PS, 9 Mi) |
9/8 high |
|
APPT |
27.7 (5.0) |
27.6 (2.2) |
2 high (stroke, Mi) |
0/0 |
|
Fibrinogen |
3.8 (1.3) |
3.5 (0.9) |
12 high (1 stroke, 1 PS, 2 CTS, 8 Mi) |
8/7 high |
|
Antithrombin 3 |
112 (15) |
108 (15) |
1 low (Mi) |
3/3 low |
|
Cholesterol |
5.4 (1.2) |
5.2 (1.3) |
5 high (1 CTS, 4 Mi) |
3/3 high |
|
Triglycerides |
1.5 (1.1) |
1.1 (0.8) |
6 high (1 CTS, 5 Mi) |
3/3 high |
|
Glucose |
4.6 (0.5) |
5.0 (0.9)* |
0 |
3/2 high |
|
Anticardiolipin ab IgG |
0.16 (0.4) |
0.03 (0.2) |
7 positive (1 stroke, 6 Mi) |
1/1 positive |
|
Anticardiolipin ab IgM |
0.14 (0.4) |
0.05 (0.2) |
4 positive (1 stroke, 3 Mi) |
3/2 positive |
|
Antinuclear antigen |
0.11 (0.3) |
0.11 (0.3) |
5 positive (1 stroke, 4 Mi) |
4/3 positive |
|
Lupus anticoagulant |
0.3 (0.2) |
0.0 (0) |
1 positive (stroke) |
1/1 positive |
|
Lues serology |
0.3 (0.2) |
0.0 (0) |
1 positive (stroke) |
0/0 |
|
Homocysteine |
9.9 (6.0) |
9.3 (7.3) |
6 high (1 stroke, 5 Mi) |
1/0 high |
|
Protein C |
113 (20) |
108 (15) |
0 |
0/0 |
|
Protein S |
71 (23) |
68 (15) |
16 low (1 stroke, 2 CTS, 13 Mi) |
18/15 low |
|
|
||||
|
*P ≤ 0.05; †p ≤ 0.01 (Wilcoxon matched pairs signed rank test). There were no significant differences when comparing the number of pathological values between patients and matched controls (n = 41 in each group, chi-square test) or migraineurs and their matched controls (n = 34 in each group). Ab, antibodies; APPT, activated partial thromboplastin time; CTS, carpal tunnel syndrome; ESR, erythrocyte sedimentation rate; Mi, migraine; MS, multiple sclerosis; PS, presyncope. |
||||
|
Ertresvg et al. BMC Medicine 2007 5:19 doi:10.1186/1741-7015-5-19 |
||||
